Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.48 | -17.45 |
| PEG Ratio (TTM) | 0.00 | -5.51 |
| P/S Ratio (TTM) | N/A | 34.30 |
| P/B Ratio (TTM) | 0.84 | 5.71 |
| P/FCF Ratio (TTM) | N/A | -146.76 |
| Price to 5YR AVG Earnings Ratio | N/A | -34.28 |
| Price to 5YR AVG FCF Ratio | N/A | -1.10 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -104.14% | 286.84% |
| ROE (TTM) | -88.74% | -4,204.52% |
| Net Profit Margin (TTM) | -1,804.18% | -1,029.21% |
| ROIC 5YR AVG | N/A | -16.30% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5,868.00% | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | -4,100.28% | N/A | N/A |
| Cash Flow | -1,317.80% | N/A | N/A |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.28 | 4.92 |
| Quick Ratio (TTM) | 2.34 | 4.90 |
| D/E Ratio (TTM) | 0.04 | 1.27 |
| Interest Coverage (TTM) | N/A | -11.13 |
| Piotroski F-Score | 4 | 3 |
| Altman Z-Score | N/A | 20.87 |
| LTL to 5YR AVG FCF | N/A | -0.53 |
| Shares Outstanding Growth 5YR AVG | N/A | 621.43% |